Medical devices, healthcare technology and the business of care
510(k) clearance · K262798

LOBO Vascular Occlusion System

Okami Medical, Inc. · Decision date Oct 6, 2026

MEDTECHLEDGER EXPLANATIONK262798

What did the FDA decide?

The FDA recorded a substantially equivalent (SESE) decision for the LOBO Vascular Occlusion System, submitted by Okami Medical, Inc. of Aliso Viejo, California, under 510(k) number K262798. The decision date is 06 October 2026; the application was received 07 August 2026. The device falls under regulation 870.3300, classification name "Device, Vascular, For Promoting Embolization," product code KRD, with the Cardiovascular medical specialty and review panel. A SESE decision is a 510(k) clearance, not a premarket approval of the device.

The record identifies the submission as a Traditional 510(k), not reviewed by a third party, not a combination product, and without an authorized Predetermined Change Control Plan. The public page does not state which predicate device was used, what the substantial-equivalence basis was, or what indications, components or labeling the clearance covers; those details would sit in the underlying FDA documents rather than this summary page. No clinical or performance conclusions are drawn here.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Oct 6, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262798
Regulatory pathway
510(k) premarket notification
Product code
KRD
Decision code
SESE
Decision date
Oct 6, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Device, Vascular, For Promoting Embolization.

Product code
KRD
FDA device class
2

FDA decision timeline

  1. K262798 received

    Application receipt date recorded by FDA.

  2. K262798 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Okami Medical, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Aliso Viejo, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records